Won the Grand Prize at RISE KANSAI FINAL 2026
FerroptoCureFerroptoCure Co., Ltd. (Representative Director: Yuji Otsuki) is pleased to announce that it has received the Grand Prize at the recently held RISE KANSAI FINAL 2026. This award recognizes our research and development capabilities, business growth potential, and efforts to address social issues.
RISE KANSAI 2026 is a forum held under the theme of “Economy × Culture × Entertainment,” with the aim of bringing together entrepreneurs, corporations, creators, and local governments to create new value and foster opportunities for co-creation. At the RISE KANSAI FINAL 2026, one of the forum’s main programs, selected startups presented their business concepts and technologies, which were then evaluated by a panel of judges composed of venture capitalists and representatives from established companies. We were awarded the Grand Prize in recognition of our efforts to develop innovative cancer treatments and the future potential of our business.
Encouraged by this award, we will further advance our research and development as well as business development efforts, striving to deliver innovative cancer treatments to patients as soon as possible. Furthermore, we will strengthen our collaborations with domestic and international pharmaceutical companies, research institutions, and investors to create new cancer treatment options through cutting-edge drug discovery research, with the goal of contributing to patients worldwide.
